Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 7 » Issue 1

Evidence to practice: treatment of anxiety in individuals with autism spectrum disorders

Authors Russell Lang, Richard Mahoney, Farah El Zein, et al

Published Date January 2011 Volume 2011:7(1) Pages 27—30

DOI http://dx.doi.org/10.2147/NDT.S10327

Published 25 January 2011

Russell Lang, Richard Mahoney, Farah El Zein, Elizabeth Delaune, Megan Amidon
Texas State University-San Marcos, TX, USA
Date of preparation: 23rd December 2010
Conflict of interest: None declared

Clinical question: What treatment improves social interactions and reduces reports of anxiety symptoms in individuals with autism spectrum disorders (ASD) and a co-occurring anxiety disorder?
Results: Systematic reviews and randomized clinical trials suggest that cognitive behavior therapy in tandem with direct instruction of social skills using applied behavior analysis intervention components may be effective for treating anxiety in individuals with high functioning ASD. For individuals with ASD, an anxiety disorder, and an intellectual disability, systematic desensitization may be effective.
Implementation: Intervention should emphasize teaching social skills. Reinforcers (ie, rewards based upon the client's interests) should be used to encourage participation in therapy. Treatment should incorporate visual aides and family involvement. Intervention components involving abstract concepts, visualization, and discussions of emotions are less useful given difficulties in abstract reasoning and communication inherent to ASD.

Keywords: autism, ASD, Asperger's, anxiety, cognitive behavior therapy, applied behavior analysis

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

The management of schizophrenia: focus on extended-release quetiapine fumarate

Peuskens J

Neuropsychiatric Disease and Treatment 2011, 7:549-564

Published Date: 21 September 2011

Moderate alcohol consumption and cognitive risk

Neafsey EJ, Collins MA

Neuropsychiatric Disease and Treatment 2011, 7:465-484

Published Date: 11 August 2011

Treatment of anemia in chronic kidney disease: known, unknown, and both

Foley RN

Journal of Blood Medicine 2011, 2:103-112

Published Date: 1 August 2011

Health psychology in primary care: recent research and future directions

Thielke S, Thompson A, Stuart R

Psychology Research and Behavior Management 2011, 4:59-68

Published Date: 1 June 2011

Role of sublingual asenapine in treatment of schizophrenia

Citrome L

Neuropsychiatric Disease and Treatment 2011, 7:325-339

Published Date: 26 May 2011

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence

McIntyre R, Yoon J, Jerrell JM, Liauw SS

Neuropsychiatric Disease and Treatment 2011, 7:319-323

Published Date: 25 May 2011

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder

Berman R, Thase M, Trivedi M, Hazel JA, Marler S, McQuade R, Carson W, Baker R, Marcus R

Neuropsychiatric Disease and Treatment 2011, 7:303-312

Published Date: 24 May 2011

Risk factors for the development of depression in patients with hepatitis C taking interferon-α

Smith KJ, Norris S, O'Farrelly C, O'Mara SM

Neuropsychiatric Disease and Treatment 2011, 7:275-292

Published Date: 15 May 2011

Recurrent major depression, ataxia, and cardiomyopathy: association with a novel POLG mutation?

Verhoeven WMA, Egger JIM, Kremer BPH, de Pont BJHB, Marcelis CLM

Neuropsychiatric Disease and Treatment 2011, 7:293-296

Published Date: 15 May 2011

Treatment of hemophilia: a review of current advances and ongoing issues

Antonio Coppola, Mirko Di Capua, Matteo Nicola Dario, et al.

Journal of Blood Medicine 2010, 1:183-195

Published Date: 30 August 2010